Cargando…
Design Challenges for HIV-1 Vaccines Based on Humoral Immunity
Autor principal: | Greenspan, Neil S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4099939/ https://www.ncbi.nlm.nih.gov/pubmed/25076950 http://dx.doi.org/10.3389/fimmu.2014.00335 |
Ejemplares similares
-
The Humoral Immune Response to BCG Vaccination
por: Tanner, Rachel, et al.
Publicado: (2019) -
Six-month humoral immune response to inactivated COVID-19 vaccine among people living with HIV
por: Zou, Shi, et al.
Publicado: (2022) -
Sculpting humoral immunity through dengue vaccination to enhance protective immunity
por: Crill, Wayne D., et al.
Publicado: (2012) -
The Humoral Immune Response to HCV: Understanding is Key to Vaccine Development
por: Cashman, Siobhán B., et al.
Publicado: (2014) -
Immunogenicity of Influenza Vaccines: Evidence for Differential Effect of Secondary Vaccination on Humoral and Cellular Immunity
por: Rosendahl Huber, Sietske K., et al.
Publicado: (2019)